Chagas Research Worldwide
Enter your Research FacilityResearchers can enter their research site by registering here. Click here for instructions to guide you in adding your research site.
Research Spotlight

Sterol Biosynthesis Inhibitors for Chagas Disease
University of Washington
Seattle, United States
We are optimizing three structural series of inhibitors of lanosterol-14alpha-demethylase (Cyp51) as anti-T. cruzi agents for the treatment of Chagas disease.
News
New compound shows promise in treating Chagas' disease - Examiner.com
'Piranha 3D' unfair to the fish - msnbc.com (blog)
A Creative Model for Vaccine Development - Forbes (blog)
Identified compound can seemingly help fight Chagas' disease - HealthJockey.com
Recent Studies
Review on Trypanosoma cruzi: Host Cell Interaction.
de Souza W, de Carvalho TM, Barrias ES
Infectivity, Pathogenicity, and Virulence of Trypanosoma cruzi Isolates from Sylvatic Animals and Vectors, and Domestic Dogs from the United States in ICR Strain Mice and SD Strain Rats.
Roellig DM, Yabsley MJ
T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection.
Cobb D, Hambright D, Smeltz RB
